RTW — RTW Biotech Opportunities Share News
0.000.00%
Last trade - 00:00- $725.25m
- $931.80m
- $34.57m
RTW Biotech Opp. - RTW Biotech Opp. – Investment Update: Kyverna IPO
RTW Biotech Opp. - Update on Arix Transaction
RTW Biotech Opp. - Acacia stake purchase & capital allocation plan
Brief: RTW Biotech Opportunities Says Bayer AG And Rtw Investments, LP Lead $162 Mln Financing
RTW Biotech Opp. - Investment Update
Brief: RTW Biotech To Acquire Arix Bioscience's Assets
RTW Biotech to acquire Arix Bioscience's assets
RTW Biotech Opp. - Director Declaration
Brief: RTW Biotech Opportunities NAV Attributable To Shares Of Co $340.9 Mln As At 31 August
Brief: Rtw Biotech Opportunities Says Rocket Pharmaceuticals Aligns with FDA on RP-A501 Trial
RTW Biotech Opp. - Update on Largest Core Portfolio Position
RTW Biotech Opp. - Half-year Report
Brief: Rtw Biotech Says Portfolio Company Beta Bionics Secured $100 Million In Funding
RCS - RTW Biotech Opp. - Edison issues update on RTW Venture Fund (RTW)
RTW Biotech Opp. - Monthly Valuation Update, Factsheet & Q2 Letter
RCS - RTW Biotech Opp. - Portfolio Company Update: Tourmaline Bio
Notice of AGM
Annual Financial Report
Brief: Rtw Venture Fund Ltd Announces A New Portfolio Company, Abdera Therapeutics